Physiotherapists' Placebo or Nocebo Communication Regarding VR in CMP
NCT ID: NCT06282757
Last Updated: 2025-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
115 participants
INTERVENTIONAL
2024-04-01
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: To determine the effect of physiotherapists' placebo or nocebo therapeutic communication about VR, on treatment credibility and expectation in patients with CMP
Study design: Web-based randomized controlled trial.
Study population: 100 participants
Intervention: The placebo intervention group will be shown an educational video about VR, containing placebo effects enhancing verbal language. The nocebo intervention group will be shown an educational video about VR, containing nocebo effects enhancing verbal language.
Primary study parameters: The primary study parameters are treatment credibility and treatment expectation. Treatment credibility and treatment expectations will be measured using the Dutch credibility and expectancy questionnaire (CEQ).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physiotherapists' Placebo or Nocebo Communication Regarding VR
NCT06307912
Effectiveness of Physiotherapist's Communication Skills on Clinical Outcomes in Chronic Musculoskeletal Patients
NCT06175884
Pain Neuroscience Education in Chronic Musculoskeletal Pain
NCT03100721
Effects of Pain Neuroscience Education and Virtual Reality in Patients With Chronic Low Back Pain
NCT06410027
PNE Delivered With a VR Headset in Outpatient LBP Patients
NCT04777877
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo group
The placebo intervention group will be shown an online educational VR video.
Video placebo communication
The placebo communication video comprises of an educational VR video containing placebo enhancing verbal language.
Nocebo group
The nocebo intervention group will be shown an online educational VR video.
Video nocebo communication
The nocebo communication video comprises of an educational VR video containing nocebo stimulating verbal language.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Video placebo communication
The placebo communication video comprises of an educational VR video containing placebo enhancing verbal language.
Video nocebo communication
The nocebo communication video comprises of an educational VR video containing nocebo stimulating verbal language.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* access to the internet
* provide informed consent
* suffers from CMP
Exclusion Criteria
* had experience with therapeutic VR
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HAN University of Applied Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bart Staal
Professor (lector)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bart Staal, PhD
Role: PRINCIPAL_INVESTIGATOR
HAN University of Applied Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HAN University of Applied Sciences
Nijmegen, Overijssel, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202302
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.